353 related articles for article (PubMed ID: 15802775)
1. [Increase in bone mineral density and its effect on fracture risk].
Sone T
Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
[TBL] [Abstract][Full Text] [Related]
2. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
3. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomised clinical trials.
Meunier PJ
Int J Clin Pract; 1999 Mar; 53(2):122-9. PubMed ID: 10344048
[TBL] [Abstract][Full Text] [Related]
5. Prevention of osteoporosis and fractures.
Ullom-Minnich P
Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
[TBL] [Abstract][Full Text] [Related]
6. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
Seeman E
Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
[TBL] [Abstract][Full Text] [Related]
7. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
Felsenberg D; Boonen S
Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
[TBL] [Abstract][Full Text] [Related]
8. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
9. [Drug treatment for the treatment of primary osteoporosis].
Halbekath J
Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):453-60. PubMed ID: 10996934
[TBL] [Abstract][Full Text] [Related]
10. [Secondary prevention of osteoporosis and identification of high risk patients].
Lehmann R; Pfeifer M; Minne H; Allolio B
Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):445-51. PubMed ID: 10996933
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses.
Delmas PD; Li Z; Cooper C
J Bone Miner Res; 2004 Feb; 19(2):330-7. PubMed ID: 14969404
[TBL] [Abstract][Full Text] [Related]
12. [Fall-preventing effect of vitamin D].
Shionoiri A
Clin Calcium; 2006 Jul; 16(7):1195-200. PubMed ID: 16816481
[TBL] [Abstract][Full Text] [Related]
13. [Goals of treatment for osteoporosis].
Nakamura T
Clin Calcium; 2008 Oct; 18(10):1389-95. PubMed ID: 18830034
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis: trials and tribulations.
Seeman E
Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
[TBL] [Abstract][Full Text] [Related]
15. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
16. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy for prevention of falls and fractures].
Ringe JD
Med Klin (Munich); 2006 Jun; 101 Suppl 1():1-5. PubMed ID: 16826362
[TBL] [Abstract][Full Text] [Related]
18. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
19. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
Bonnick SL; Shulman L
Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
[TBL] [Abstract][Full Text] [Related]
20. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
